Lucerastat, an iminosugar for substrate reduction therapy in Fabry disease: preclinical evidence by Priestman, D, Welford, R, Platt, F, Muhlemann, A, Garzotti, M, Deymier, C, Ertel, E, Iglarz, M, Baldoni, D, Probst, M

Lucerastat, an iminosugar for substrate reduction therapy in Fabry Disease: Preclinical evidence by Welford, R, Mühleman, A, Priestman, D, Garzotti, M, Deymier, C, Ertel, E, Iglarz, M, Morand, O, Priestman, D, Platt, F, Probst, M